[google-translator]

T4

Disorder: Endocrine

Condition: Primary and Secondary Congenital Hypothyroidism

Biomarker: Thyroxine (T4)

The T4 assay is intended for the quantitative determination of Thyroxine (T4) concentrations in dried neonatal whole blood specimens. Measurement of T4 is used as a primary or secondary screen in the diagnosis and treatment of congenital hypothyroidism in newborns, an inborn error of thyroid hormone production. 

For more information, visit Congenital Hypothyroidism

PRODUCT HIGHLIGHTS

• Options of 3 hour or overnight assay protocols – Flexible timeline to fit your laboratory’s needs
• Single plate elution allows for semi-plexing with other immunoassays – Reduced microplate usage with efficient workflow
• Multi-analyte calibrators and controls in DBS format – Simplified workflow with complementary assays

For In Vitro Diagnostic Use.  This device is intended for use by trained, qualified laboratory personnel.

PRODUCT ORDERING INFORMATION

SPOTCHECK® NEONATAL T4 MICROPLATE REAGENT KIT CONFIGURATIONS

PART NO.DESCRIPTIONCONTENTS
85-4000-05K/KE5 PlateDried blood spot calibrators and controls, antibody coated microplates, all reagents
85-4000-20K/KE20 PlateDried blood spot calibrators and controls, antibody coated microplates, all reagents
DOWNLOAD OUR BROCHURE